A detailed history of Virtus ETF Advisers LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 6,006 shares of CELC stock, worth $79,219. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,006
Previous 5,901 1.78%
Holding current value
$79,219
Previous $96,000 7.29%
% of portfolio
0.04%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.98 - $19.15 $1,467 - $2,010
105 Added 1.78%
6,006 $89,000
Q2 2024

Aug 14, 2024

BUY
$14.1 - $20.78 $83,204 - $122,622
5,901 New
5,901 $96,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $197M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.